Insulin-like growth factor binding protein-1 in NIDDM: Relationship with the insulin resistance syndrome

Clinical Endocrinology

Volumn 50, Issue 2, 1999, Pages 221-228

  Mohamed Ali, V ^a   Pinkney, J H ^a,b   Panahloo, A ^a,d   Cwyfan Hughes, S ^c   Holly, J M P ^c   Yudkin, J S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROINSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETIC ANGIOPATHY; FEMALE; GROWTH REGULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN; PROTEIN PRECURSORS; REGRESSION ANALYSIS;

EID: 0033055656     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00647.x     Document Type: Article

References (35)

1. Bar, R.S., Boes, M., Clemmons, D.R., Busby, W.H., Sandra, A., Dake, B.L. & Booth, B.A. (1990) Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF binding proteins in the rat heart. Endocrinology, 127, 479-499.
2. Baxter, R.C. (1994) Insulin-like growth factor binding proteins in the human circulation: a review. Hormone Research, 42, 140-144.
3. Bowsher, R.R., Lee, W.H., Apathy, J.M., O'Brien, P.J., Ferguson, A.L. & Henry, D.P. (1991) Measurement of insulin-like growth factor binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. Journal of Clinical Endocrinology and Metabolism, 79, 1887-1890.
4. Campbell, P.G., Novak, J.F., Yanosick, T.B. & McMaster, J.H. (1992) Involvement of the plasmin system in dissociation of the insulin-like growth factor binding protein complex. Endocrinology, 130, 1401-1412.
5. Cheetham, T.D., Taylor, A., Holly, J.M., Clayton, K., Cwyfan-Hughes, S. & Dunger, D.B. (1994) The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I. IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus. Journal of Endocrinology, 142, 367-374.
6. Cohen, P., Fielder, P.J., Hasegawa, Y., Firsch, H., Giudice, L.C. & Rosenfeld, R.G. (1991) Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinological (Copenh), 124, 74-85.
7. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
8. Guler, H.-P., Zapf, J. & Froesch, E.R. (1987) Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. New England Journal of Medicine, 317, 137-140.
9. Holly, J.M.P. (1991) The physiological role of IGFBP-1. Acta Endocrinological (Copenh), 124, 55-62.
10. Holly, J.M., Biddlecombe, R.A., Dunger, D.B., Edge, J.A., Amiel, S.A., Howell, R., Chard, T., Rees, L.H. & Wass, J.A. (1988) Circadian variation of GH-dependent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?. Clinical Endocrinology, 29, 667-675.
11. Hopkins, N.J., Jakeman, P.M., Cwyfan-Hughes, S.C. & Holly, J.M.P. (1994a) Changes in circulating insulin-like growth factor binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. Journal of Clinical Endocrinological Metabolism, 79, 1887-1890.
12. Hopkins, K.D., Lehmann, E.D., Parker, J.R. & Gosling, R.G. (1994b) Insulin-like growth factor binding protein-1 is correlated with low density lipoprotein cholesterol in normal subjects. Journal of Endocrinology, 140, 521-524.
13. Jarvelainen, H., Ronnemaa, T. & Kallio, V. (1986) Insulin-like growth factor-1 in type 2 (non-insulin dependent) diabetics with myocardial infarction and without macroangiopathy. Atherosclerosis, 59, 335-340.
14. Juhan-Vague, I., Thompson, S.G. & Jespersen, J. (1993) Involvement of the homeostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arteriosclerosis and Thrombosis, 13, 1865-1873.
15. Kooistra, T., Bosma, T.J., Tons, H.A., van den Berg, A.P., Meyer, P. & Princen, H.M. (1989) Plasminogen activator inhibitor I: Biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thrombosis and Haemostasis, 62, 723-728.
16. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Rosen, T., Lindstedt, G., Lundberg, P.A. & Bengtsson, B.A. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology, 41, 351-357.
17. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations. Diabetologia, 28, 412-419.
18. Mohamed-Ali, V., Gould, M.M., Gillies, S., Goubet, S., Yudkin, J.S. & Haines, A.P. (1995) Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - evidence against a modulating role for insulin. Diabetologia, 38, 1110-1116.
19. Mohamed-Ali, V., Nagi, D.K. & Yudkin, J.S. (1996) Simple, sensitive microplate IRMAs for intact and des 31,32 proinsulin - Comparisons with HPLC and cellulose IRMAs. Clinical Chemistry, 42, 977-979.
20. Nagi, D.K., Hendra, T.J., Ryle, A.J., Cooper, T.M., Temple, R.C., Clark, P.M., Schneider, A.E., Hales, C.N. & Yudkin, J.S. (1990) The relationship of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type-2 (non-insulin dependent) diabetic subjects. Diabetologia, 33, 532-537.
21. Nagi, D.K., Mohamed-Ali, V., Jain, S.K., Walji, S. & Yudkin, J.S. (1996) Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (Type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabetic Medicine, 13, 59-64.
22. Oppenheimer, M.J., Sundquist, K. & Bierman, E.L. (1989) Down-regulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-1. Diabetes, 38, 117-122.
23. Oscarsson, J., Lundstam, U., Gustaffson, B., Wilton, P., Eden, S. & Wiklund, O. (1995) Recombinant human insulin-like growth factor-I decreases serum lipoprotein (a) concentrations in normal adult men. Clinical Endocrinology, 42, 673-676.
24. Ostlund, R.E., Yang, J.W., Heath-Monnig, E. & Semenkovich, C.F. (1994) Increased low density lipoprotein receptor expression induced by insulin-like growth factor 1 in cultured fibroblasts. Molecular Endocrinology, 8, 904-909.
25. Peavy, D.E., Brunner, M.R., Duckworth, W.C., Hooker, C.S. & Frank, B.H. (1985) Receptor binding and biological potency of several forms (conversion intermediates) of human proinsulin. Journal of Biological Chemistry, 260, 13989-13994.
26. Pfeiffer, A. & Schatz, H. (1995) Diabetic microvascular complications and growth factors. Experimental Clinical Endocrinology and Diabetes, 103, 7-14.
27. Poulos, J.E., Leggett-Frazier, N., Khazanie, P., Long, S., Sportsman, R., MacDonald, K. & Caro, J.F. (1994) Circulating insulin-like growth factor-I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss. Hormone and Metabolism Research, 26, 478-480.
28. Schmid, C. (1995) Insulin-like growth factors. Cell Biology International, 19, 445-457.
29. Schneider, D.J., Nordt, T.K. & Sobel, B.E. (1992) Stimulation of expression of plasminogen activator inhibitor type-I in endothelial cells. Diabetes, 41, 890-895.
30. Sodoyez-Goffaux, F., Sodoyez, J.C., Koch, M., DeVos, C.J. & Frank, B.H. (1988) Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats. Diabetologia, 31, 848-854.
31. Suikkari, A.M., Sane, T., Seppala, M., Yki-Jarvinen, H., Karonen, S.L. & Koivisto, V.A. (1989) Prolonged exercise increases serum insulin-like growth factor concentrations. Journal of Clinical Endocrinology and Metabolism, 68, 141-144.
32. Unterman, T.G., Oehler, D.T., Murphy, L.J. & Lacson, R.G. (1991) Multihormonal regulation of insulin-like growth factor binding protein-1 in rat H411E hepatoma cells: the dominant role of insulin. Endocrinology, 128, 2693-2701.
33. Wang, H.S., Perry, L.A., Kanisius, J., Iles, R.K., Holly, J.M.P. & Chard, T. (1991) Purification and assay of insulin-like growth factor binding protein-1: measurement of circulating levels throughout pregnancy. Journal of Endocrinology, 128, 161-168.
34. Zenobi, P.D., Jaeggi-Groisman, S.E., Riesen, W.F., Roder, M.E. & Froesch, E.R. (1992a) Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. Journal of Clinical Investigations, 90, 2234-2241.
35. Zenobi, P.D., Graf, S., Ursprung, H. & Froesch, E.R. (1992b) Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. Journal of Clinical Investigations, 89, 1908-1913.